Robert L. Rosiello
CIK 1645041 · EVP, Corp Dev & Strategy · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
16
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SANA | Director | — | $2.68 | — | $0 | 2 | 2026-06-05 |
| MCRB | Director | — | $5.70 | — | $0 | 1 | 2025-08-06 |
| Omega Therapeutics, Inc. (OMGA) Delisted | Director | — | $0.14 | — | $0 | 1 | 2024-10-04 |
| EVLO | Director | — | $0.00 | — | $0 | 2 | 2023-06-12 |
| Axcella Health Inc. (AXLA) Delisted | Director | — | $0.40 | — | $0 | 1 | 2022-11-18 |
Recent Filings · Page 2 of 2
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2016-05-16 | — | Grant (A) | +84,975 | $0 | |
| 2015-10-22 | — | Grant (A) | +7,875 | $0 | |
| 2015-08-03 | — | Buy (P) | +7,875 | $2.00M | |
| 2015-07-22 | — | Grant (A) | +12,900 | $0 | |
| 2015-07-02 | — | Grant (A) | +408,000 | $0 | |
| 2015-06-16 | — | Buy (P) | +12,900 | $3.00M |
Showing 11–16 of 16
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.